Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jun;62(2):151-61.
doi: 10.2332/allergolint.13-RAI-0564.

New insights into atopic dermatitis: role of skin barrier and immune dysregulation

Affiliations
Review

New insights into atopic dermatitis: role of skin barrier and immune dysregulation

Donald Y M Leung. Allergol Int. 2013 Jun.

Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin disease that is often associated with the development of food allergy and asthma. New insights into AD reveals an important role for structural abnormalities in the epidermis resulting in a leaky epithelial barrier as well as chronic immune activation that contribute to the pathophysiology of this common skin disease. Patients with AD have a predisposition to colonization or infection by microbial organisms, most notably Staphylococcus aureus and herpes simplex virus (HSV). Measures directed at healing and protecting the skin barrier and controlling the immune activation are needed for effective management of AD. Early intervention may improve outcomes for AD as well as reduce the systemic allergen sensitization that may lead to associated allergic diseases in other organs.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: No potential conflict of interest was disclosed.

Figures

Fig. 1
Fig. 1
Immunologic pathways involved in different phases of atopic dermatitis. Published with permission from: Gittler JK, Shemer A, Suárez-Fariñas M, et al. Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J Allergy Clin Immunol 2012; 130: 1344–54.
Fig. 2
Fig. 2
Comparison of clinical and biophysical features of atopic dermatitis patients with (ADFLG) and without (ADNON-FLG) filaggrin mutations. Published with permission from: McAleer MA, Irvine AD. The multifunctional role of filaggrin in allergic skin disease. J Allergy Clin Immunol 2013; 131: 280–91.
Fig. 3
Fig. 3
Stepwise approach for management of AD according to disease severity.

References

    1. Boguniewicz M, Leung DYM. Atopic dermatitis: A disease of altered skin barrier and immune dysregulation. Immunol Rev 2011;242:233–46. - PMC - PubMed
    1. Yaghmaie P, Koudelka CW, Simpson EL. Mental health comorbidity in patients with atopic dermatitis. J Allergy Clin Immunol 2013;131:428–33. - PMC - PubMed
    1. Slattery MJ, Essex MJ, Paletz EM et al. Depression, anxiety, and dermatologic quality of life in adolescents with atopic dermatitis. J Allergy Clin Immunol 2011;128:668–71. - PMC - PubMed
    1. Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: data from the 2003 National Survey of Children’s Health. J Invest Dermatol 2011; 131:67–73. - PMC - PubMed
    1. Xu F, Yan S, Li F et al. Prevalence of childhood atopic dermatitis: an urban and rural community-based study in Shanghai, China. PLoS One 2012;7:e36174. - PMC - PubMed

MeSH terms